African Programme for Onchocerciasis Control 1995-2015: Model-Estimated Health Impact and Cost

A Kim; AP Plaisier; AP Plaisier; AP Plaisier; AP Plaisier; AP Plaisier; AS Goldman; B Benton; B Boatin; BO Duke; C Bottomley; CD Mackenzie; Dik Habbema; Donald A. P. Bundy; ES Alley; GA Ozoh; Grace Fobi; Honorat G. M. Zouré; J Gardon; J. Lennert Veerman; Jan Hendrik Richardus; JM Tielsch; K Awadzi; Koffi B. Agblewonu; L Diawara; LM Alonso; Luc E. Coffeng; M Noma; M Shah; M Walker; M Winnen; María-Gloria Basáñez; ME Murdoch; MG Basáñez; Michele E. Murdoch; Mounkaila Noma; MP Little; O Onwujekwe; Sake J. de Vlas; SD Pion; Uche V. Amazigo; Wilma A. Stolk; Y Dadzie

African Programme for Onchocerciasis Control 1995-2015: Model-Estimated Health Impact and Cost

Authors: A Kim
AP Plaisier
AP Plaisier
AP Plaisier
AP Plaisier
AP Plaisier
AS Goldman
B Benton
B Boatin
BO Duke
C Bottomley
CD Mackenzie
Dik Habbema
Donald A. P. Bundy
ES Alley
GA Ozoh
Grace Fobi
Honorat G. M. Zouré
J Gardon
J. Lennert Veerman
Jan Hendrik Richardus
JM Tielsch
K Awadzi
Koffi B. Agblewonu
L Diawara
LM Alonso
Luc E. Coffeng
M Noma
M Shah
M Walker
M Winnen
María-Gloria Basáñez
ME Murdoch
MG Basáñez
Michele E. Murdoch
Mounkaila Noma
MP Little
O Onwujekwe
Sake J. de Vlas
SD Pion
Uche V. Amazigo
Wilma A. Stolk
Y Dadzie
Publication date: 1 January 2013
Publisher: 'Public Library of Science (PLoS)'
Doi

Abstract

Background: Onchocerciasis causes a considerable disease burden in Africa, mainly through skin and eye disease. Since 1995, the African Programme for Onchocerciasis Control (APOC) has coordinated annual mass treatment with ivermectin in 16 countries. In this study, we estimate the health impact of APOC and the associated costs from a program perspective up to 2010 and provide expected trends up to 2015